Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 18;24(10):8958.
doi: 10.3390/ijms24108958.

Recent Advances in Biochemistry and Molecular Biology of Infectious Diseases

Affiliations
Editorial

Recent Advances in Biochemistry and Molecular Biology of Infectious Diseases

Salvatore Giovanni De-Simone. Int J Mol Sci. .

Abstract

This Editorial highlights the various observations made in the Special Issue of the International Journal of Molecular Sciences on "Recent Advances in Biochemistry and Molecular Biology of Infectious Diseases" [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Federico M. How do anti-SARS-CoV-2 mRNA vaccines protect from severe disease? Int. J. Mol. Sci. 2022;23:10374. doi: 10.3390/ijms231810374. - DOI - PMC - PubMed
    1. Nishi K., Yoshimoto S., Nishi S., Nishi T., Nishi R., Tanaka T., Tsunoda T., Imai K., Tanaka H., Hotta O., et al. Epipharyngeal abrasive therapy (EAT) reduces the mRNA expression of major proinflammatory cytokine IL-6 in chronic epipharyngitis. Int. J. Mol. Sci. 2022;23:9205. doi: 10.3390/ijms23169205. - DOI - PMC - PubMed
    1. Nishi K., Yoshimoto S., Nishi S., Tsunoda T., Ohno J., Yoshimura M., Hiromatsu K., Yamano T. Epipharyngeal abrasive therapy down-regulates the expression of SARS-CoV-2 entry factors ACE2 and TMPRSS2. In Vivo. 2022;36:371–374. doi: 10.21873/invivo.12712. - DOI - PMC - PubMed
    1. Figueres M., Mansuy J.M., Vasseur S., Claverie N., Lougarre C., Soulier F., Trémeaux P., Izopet J. Omicron Wave SARS-CoV-2 diagnosis: Evaluation of saliva, anterior nasal, and nasopharyngeal swab samples. Microbiol. Spectr. 2022;10:e0252122. doi: 10.1128/spectrum.02521-22. - DOI - PMC - PubMed
    1. Kritikos A., Caruana G., Lazor-Blanchet C., Currat M., Chiche J.D., Vollenweider P., Bart P.A., Opota O., Greub G. Comparison of nasopharyngeal and saliva swab nucleic acid amplification and rapid antigen testing to detect omicron SARS-CoV-2 variant of concern: A prospective clinical trial (OMICRON) Microbiol. Spectr. 2022;10:e0392322. doi: 10.1128/spectrum.03923-22. - DOI - PMC - PubMed

Publication types